Complete News, Your Way.
Published loading...Updated

Ozempic label now notes potential side effect of intestinal blockage

  • The FDA has updated the label of the diabetes drug Ozempic to acknowledge reports of blocked intestines, while also acknowledging reports of a similar condition for its sister drug Wegovy.
  • Ozempic and Wegovy have seen a surge in popularity and are known to cause gastrointestinal side effects such as delayed gastric emptying, nausea, and vomiting.
  • A lawsuit has been filed against Novo Nordisk and Eli Lilly by a woman who claims severe gastrointestinal events and resulting injury from using Ozempic and Mounjaro.
Insights by Ground AI
Does this summary seem wrong?

37 Articles

All
Left
4
Center
30
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 88% of the sources are Center
88% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CBS News broke the news in on Wednesday, September 27, 2023.
Sources are mostly out of (0)